Objective: To define the strengths and weaknesses of existing research
on the natural history of cervical squamous intraepithelial lesions (
SIL) and to estimate rates of progression and regression without treat
ment. Data Sources: Studies of women whose cervical smears showed squa
mous atypia or worse and who were observed for a minimum of 6 months w
ere identified by a search of MEDLINE from 1966 to 1996, Current Conte
nts, the Federal Research in Progress database, and references of revi
ew articles and identified studies, and by experts in the field. Metho
ds of Study Selection: Fifteen of 81 studies were eligible for data ex
traction. To be eligible, studies had to report a minimum of 6 months'
follow-up without treatment; relate entry cytologic findings to outco
mes; and report entry cytologic findings so that the study population
could be stratified into categories oi: atypical cells of undetermined
significance (ASCUS), low-grade SIL, or high-grade SIL. Studies publi
shed before 1970 were excluded. Tabulation, Integration, and Results:
Eligible studies, representing 27,929 patients, were stratified accord
ing to entry cytologic findings. The following rates of progression to
high-grade SIL at 24 months were found: ASCUS, 7.13% (95% confidence
interval [CI] 0.8%, 13.5%); low-grade SIL, 20.81% (6.08%, 35.55%); and
high-grade SIL, 23.37% (12.82%, 32.92%). The following rates of invas
ive cancer at 24 months were found: ASCUS, 0.25% (0%, 2.25%); low-grad
e SIL, 0.15% (0%, 0.71%); and high-grade SIL, 1.44% (0%, 3.95%). The f
ollowing rates of regression to normal were found: ASCUS, 68.19% (57.5
1%, 78.86%); low-grade SIL, 47.39% (35.92%, 58.86%); and high-grade SI
L, 35.03% (16.57%, 53.49%). Study heterogeneity was not explained by r
egression analysis of study level variables. Conclusion: Our findings
for borderline and low-grade abnormal cervical cytologic results sugge
st a relatively low risk of invasive cervical cancer with observation
up to 24 months and support the clinical policy of early colposcopy fo
r high-grade lesions. (Obstet Gynecol 1998;92:727-35. (C) 1998 by The
American College of Obstetricians and Gynecologists.).